Fetal growth indicators and perfluorinated chemicals: A study in the Danish national birth cohort

American Journal of Epidemiology

Volumn 168, Issue 1, 2008, Pages 66-72

  Fei, Chunyuan ^a   McLaughlin, Joseph K ^b,c   Tarone, Robert E ^b,c   Olsen, Jørn ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b INTERNATIONAL EPIDEMIOLOGY INSTITUTE   (United States)

^c VANDERBILT INGRAM CANCER CENTER   (United States)

^d AARHUS UNIVERSITY   (Denmark)

Author keywords

Birth weight; Fetal development; Perfluorooctane sulfonic acid; Perfluorooctanoic acid; Prenatal exposure delayed effects

Indexed keywords

PERFLUORO COMPOUND; PERFLUOROOCTANESULFONIC ACID; PERFLUOROOCTANOIC ACID;

COHORT ANALYSIS; EMBRYONIC DEVELOPMENT; ORGANIC POLLUTANT; PREGNANCY; SKELETON; WEIGHT;

ARTICLE; BODY HEIGHT; CONFIDENCE INTERVAL; ENVIRONMENTAL EXPOSURE; FEMALE; FETUS GROWTH; GROWTH INHIBITION; HEAD CIRCUMFERENCE; HUMAN; INFANT; MALE; MATERNAL BLOOD; MIDWIFE; NEWBORN; NURSE; ORGAN GROWTH; PLACENTA WEIGHT; PREGNANCY OUTCOME; PREGNANT WOMAN; STATISTICAL SIGNIFICANCE;

ADULT; ALKANESULFONIC ACIDS; BIRTH WEIGHT; COHORT STUDIES; DENMARK; FEMALE; FETAL DEVELOPMENT; FLUOROCARBONS; HUMANS; INFANT, NEWBORN; MALE; OCTANOIC ACIDS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; REGISTRIES;

EID: 45849137415     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwn095     Document Type: Article

References (35)

1. Butenhoff JL, Olsen GW, Pfahles-Hutchens A. The applicability of biomonitoring data for perfluorooctanesulfonate to the environmental public health continuum. Environ Health Perspect 2006;114:1776-82.
2. Environmental Protection Agency. Basic information on PFOA. Washington, DC: Environmental Protection Agency, 2006. (http://www.epa.gov/opptintr/pfoa/ pubs/pfoainfo.htm).
3. Environmental Protection Agency. Revised draft hazard assessment of perfluorooctanoic acid and its salts. Washington, DC: Environmental Protection Agency, 2002. (http://www.fluoridealert.org/pesticides/pfoa.epa.nov.4.2002.pdf).
4. Dooley EE, ed. PFOA to be eliminated. Environ Health Perspect 2007;114:A217.
5. Calafat AM, Wong LY, Kuklenyik Z, et al. Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons to NHANES 1999-2000. Environ Health Perspect 2007;115:1596-602.
6. Butenhoff JL, Kennedy GL Jr, Frame SR, et al. The reproductive toxicology of ammonium perfluorooctanoate (APFO) in the rat. Toxicology 2004;196:95-116.
7. Case MT, York RG, Christian MS. Rat and rabbit oral developmental toxicology studies with two perfluorinated compounds. Int J Toxicol 2001;20:101-9.
8. Grasty RC, Wolf DC, Grey BE, et al. Prenatal window of susceptibility to perfluorooctane sulfonate-induced neonatal mortality in the Sprague-Dawley rat. Birth Defects Res B Dev Reprod Toxicol 2003;68:465-71.
9. Luebker DJ, Case MT, York RG, et al. Two-generation reproduction and cross-foster studies of perfluorooctanesulfonate (PFOS) in rats. Toxicology 2005;215:126-48.
10. Luebker DJ, York RG, Hansen KJ, et al. Neonatal mortality from in utero exposure to perfluorooctanesulfonate (PFOS) in Sprague-Dawley rats: dose-response, and biochemical and pharmacokinetic parameters. Toxicology 2005;215:149-69.
11. Lau C, Butenhoff JL, Rogers JM. The developmental toxicity of perfluoroalkyl acids and their derivatives. Toxicol Appl Pharmacol 2004;198:231-41.
12. Lau C, Thibodeaux JR, Hanson RG, et al. Effects of perfluorooctanoic acid exposure during pregnancy in the mouse. Toxicol Sci 2006;90:510-18.
13. Thibodeaux JR, Hanson RG, Rogers JM, et al. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: maternal and prenatal evaluations.Toxicol Sci 2003;74:369-81.
14. Wolf CJ, Fenton SE, Schmid JE, et al. Developmental toxicity of perfluorooctanoic acid in the CD-1 mouse after cross-foster and restricted gestational exposures. Toxicol Sci 2007;95:462-73.
15. Apelberg BJ, Witter FR, Herbstman JB, et al. Cord serum concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birth. Environ Health Perspect 2007;115:1670-6.
16. Grice MM, Alexander BH, Hoffbeck R, et al. Self-reported medical conditions in perfluorooctanesulfonyl fluoride manufacturing workers. J Occup Environ Med 2007;49:722-9.
17. Fei CY, McLaughlin JK, Tarone RE, et al. Perfluorinated chemicals and fetal growth: a study within the Danish National Birth Cohort. Environ Health Perspect 2007;115:1677-82.
18. Olsen J, Melbye M, Olsen SF, et al. The Danish National Birth Cohort - its background, structure and aim. Scand J Public Health 2001;29:300-7.
19. Ehresman DJ, Froehlich JW, Olsen GW, et al. Comparison of human whole blood, plasma, and serum matrices for the determination of perfluorooctanesulfonate (PFOS), perfluorooctanoate (PFOA), and other fluorochemicals. Environ Res 2007;103:176-84.
20. Tittlemier SA, Ryan JJ, Van Oostdam J. Presence of anionic perfluorinated organic compounds in serum collected from northern Canadian populations. Organohalogen Compounds 2004;66:4009-14.
21. Midasch O, Schettgen T, Angerer J. Pilot study on the perfluorooctanesulfonate and perfluorooctanoate exposure of the German general population. Int J Hyg Environ Health 2006;209:489-96.
22. Forsen T, Eriksson JG, Tuomilehto J, et al. Growth in utero and during childhood among women who develop coronary heart disease: longitudinal study. BMJ 1999;319:1403-7.
23. Barker DJ, Forsen T, Uutela A, et al. Size at birth and resilience to effects of poor living conditions in adult life: longitudinal study. BMJ 2001;323:1273-6.
24. Butenhoff J, Costa G, Elcombe C, et al. Toxicity of ammonium perfluorooctanoate in male cynomolgus monkeys after oral dosing for 6 months. Toxicol Sci 2002;69:244-57.
25. Olsen GW, Gilliland FD, Burlew MM, et al. An epidemiologic investigation of reproductive hormones in men with occupational exposure to perfluorooctanoic acid. J Occup Environ Med 1998;40:614-20.
26. Olsen GW, Burris JM, Burlew MM, et al. Epidemiologic assessment of worker serum perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) concentrations and medical surveillance examinations. J Occup Environ Med 2003;45:260-70.
27. Olsen GW, Zobel LR. Assessment of lipid, hepatic, and thyroid parameters with serum perfluorooctanoate (PFOA) concentrations in fluorochemical production workers. Int Arch Occup Environ Health 2007;81:231-46.
28. Emmett EA, Zhang H, Shofer FS, et al. Community exposure to perfluorooctanoate: relationships between serum levels and certain health parameters. J Occup Environ Med 2006;48:771-9.
29. Chang SC, Thibodeaux JR, Eastvold ML, et al. Negative bias from analog methods used in the analysis of free thyroxine in rat serum containing perfluorooctanesulfonate (PFOS). Toxicology 2007;234:21-33.
30. Henderson WM, Smith MA. Perfluorooctanoic acid and perfluorononanoic acid in fetal and neonatal mice following in utero exposure to 8-2 fluorotelomer alcohol. Toxicol Sci 2007;95:452-61.
31. Martin JW, Mabury SA, Solomon KR, et al. Bioconcentration and tissue distribution of perfluorinated acids in rainbow trout (Oncorhynchus mykiss). Environ Toxicol Chem 2003;22:196-204.
32. Karrman A, Ericson I, van Bavel B, et al. Exposure of perfluorinated chemicals through lactation: levels of matched human milk and serum and a temporal trend, 1996-2004, in Sweden. Environ Health Perspect 2007;115:226-30.
33. Eskenazi B, Harley K, Bradman A, et al. Association of in utero organophosphate pesticide exposure and fetal growth and length of gestation in an agricultural population. Environ Health Perspect 2004;112:1116-24.
34. Fenster L, Eskenazi B, Anderson M, et al. Association of in utero organochlorine pesticide exposure and fetal growth and length of gestation in an agricultural population. Environ Health Perspect 2006;114:597-602.
35. Sagiv SK, Tolbert PE, Altshul LM, et al. Organochlorine exposures during pregnancy and infant size at birth. Epidemiology 2007;18:120-9.